Cargando…
Potentiating the Antitumor Activity of Cytotoxic T Cells via the Transmembrane Domain of IGSF4 That Increases TCR Avidity
A robust T-cell response is an important component of sustained antitumor immunity. In this respect, the avidity of TCR in the antigen-targeting of tumors is crucial for the quality of the T-cell response. This study reports that the transmembrane (TM) domain of immunoglobulin superfamily member 4 (...
Autores principales: | Kim, Hye-Ran, Park, Jeong-Su, Fatima, Yasmin, Kausar, Maiza, Park, Jin-Hwa, Jun, Chang-Duk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882689/ https://www.ncbi.nlm.nih.gov/pubmed/33597944 http://dx.doi.org/10.3389/fimmu.2020.591054 |
Ejemplares similares
-
IGSF4 is a novel TCR ζ-chain–interacting protein that enhances TCR-mediated signaling
por: Kim, Hye-Ran, et al.
Publicado: (2011) -
The Quest for the Best: How TCR Affinity, Avidity, and Functional Avidity Affect TCR-Engineered T-Cell Antitumor Responses
por: Campillo-Davo, Diana, et al.
Publicado: (2020) -
Overall avidity declines in TCR repertoires during latent CMV but not EBV infection
por: Couturaud, Barbara, et al.
Publicado: (2023) -
Novel Immunomodulatory Proteins Generated via Directed Evolution of Variant IgSF Domains
por: Levin, Steven D., et al.
Publicado: (2020) -
Single-Cell Transcriptomics Reveals Killing Mechanisms of Antitumor Cytotoxic CD4(+) TCR-T Cells
por: Liang, Yanling, et al.
Publicado: (2022)